Actually, we observed that knockdown of HIF-1α, but not HIF-2α, increased the TRAIL sensitivity of a prostate (DU145) and a cervical cancer cell line (HeLa) (Figure 3b). The gene discussed is HIF1A; the disease is cervical carcinoma.